Vor Biopharma Inc (NASDAQ: VOR) on Tuesday, plunged -47.66% from the previous trading day, before settling in for the closing price of $18.8. Within the past 52 weeks, VOR’s price has moved between $2.62 and $65.80.
During the last 5-year period, the sales drop of Healthcare Sector giant was -38.02%. The company achieved an average annual earnings per share of -1018.96%. With a float of $5.67 million, this company’s outstanding shares have now reached $6.28 million.
Vor Biopharma Inc (VOR) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Vor Biopharma Inc is 17.06%, while institutional ownership is 20.33%. The most recent insider transaction that took place on Oct 29 ’25, was worth 6,343,284. In this transaction Director of this company sold 251,518 shares at a rate of $25.22, taking the stock ownership to the 804,231 shares. Before that another transaction happened on Oct 28 ’25, when Company’s Director sold 124,311 for $27.42, making the entire transaction worth $3,408,230. This insider now owns 1,055,749 shares in total.
Vor Biopharma Inc (VOR) Earnings and Forecasts
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -8 earnings per share (EPS) for the period topping the consensus outlook (set at -8.09) by 0.09. Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -1018.96% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 57.86% during the next five years compared to -38.02% drop over the previous five years of trading.
Vor Biopharma Inc (NASDAQ: VOR) Trading Performance Indicators
Vor Biopharma Inc (VOR) is currently performing well based on its current performance indicators. A quick ratio of 3.49 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -273.28, a number that is poised to hit -3.45 in the next quarter and is forecasted to reach -6.08 in one year’s time.
Technical Analysis of Vor Biopharma Inc (VOR)
Looking closely at Vor Biopharma Inc (NASDAQ: VOR), its last 5-days average volume was 2.09 million, which is a jump from its year-to-date volume of 0.43 million. As of the previous 9 days, the stock’s Stochastic %D was 4.21%.
During the past 100 days, Vor Biopharma Inc’s (VOR) raw stochastic average was set at 8.56%, which indicates a significant increase from 4.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.01 in the past 14 days, which was lower than the 4.54 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $30.70, while its 200-day Moving Average is $24.67. However, in the short run, Vor Biopharma Inc’s stock first resistance to watch stands at $10.37. Second resistance stands at $10.89. The third major resistance level sits at $11.58. If the price goes on to break the first support level at $9.16, it is likely to go to the next support level at $8.47. Should the price break the second support level, the third support level stands at $7.95.
Vor Biopharma Inc (NASDAQ: VOR) Key Stats
Market capitalization of the company is 67.32 million based on 6,854K outstanding shares. Right now, sales total 0 K and income totals -116,914 K. The company made 0 K in profit during its latest quarter, and -1,574 M in sales during its previous quarter.
